Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.

Walter SD, Chao DL, Feuer W, Schiffman J, Char DH, Harbour JW.

JAMA Ophthalmol. 2016 Apr 28. doi: 10.1001/jamaophthalmol.2016.0913. [Epub ahead of print]

PMID:
27123792
2.

Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.

Decatur CL, Ong E, Garg N, Anbunathan H, Bowcock AM, Field MG, Harbour JW.

JAMA Ophthalmol. 2016 Apr 28. doi: 10.1001/jamaophthalmol.2016.0903. [Epub ahead of print]

PMID:
27123562
3.

The state of melanoma: challenges and opportunities.

Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA.

Pigment Cell Melanoma Res. 2016 Apr 17. doi: 10.1111/pcmr.12475. [Epub ahead of print]

PMID:
27087480
4.

PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.

Field MG, Decatur CL, Kurtenbach S, Gezgin G, van der Velden PA, Jager MJ, Kozak KN, Harbour JW.

Clin Cancer Res. 2016 Mar 1;22(5):1234-42. doi: 10.1158/1078-0432.CCR-15-2071.

PMID:
26933176
5.

Uveal and Conjunctival Melanoma: Close Together-but Only Distantly Related.

Harbour JW.

Oncology (Williston Park). 2016 Jan;30(1):44, 48. No abstract available.

6.

EMT-associated factors promote invasive properties of uveal melanoma cells.

Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG.

Mol Vis. 2015 Aug 25;21:919-29. eCollection 2015.

7.

Spectral-Domain Optical Coherence Tomography of Presumed Solitary Circumscribed Retinal Astrocytic Proliferation Versus Astrocytic Hamartoma.

Schwartz SG, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):586-8. doi: 10.3928/23258160-20150521-13.

PMID:
26057765
8.

Epigenetic reprogramming of melanoma cells by vitamin C treatment.

Gustafson CB, Yang C, Dickson KM, Shao H, Van Booven D, Harbour JW, Liu ZJ, Wang G.

Clin Epigenetics. 2015 Apr 29;7(1):51. doi: 10.1186/s13148-015-0087-z. eCollection 2015.

9.

Hydroxyapatite versus polyethylene orbital implants for patients undergoing enucleation for uveal melanoma.

Chao DL, Harbour JW.

Can J Ophthalmol. 2015 Apr;50(2):151-4. doi: 10.1016/j.jcjo.2014.11.007.

PMID:
25863856
10.

Gene expression profiling and regression rate of irradiated uveal melanomas.

Rao RC, Khan M, Badiyan SN, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):333-7. doi: 10.3928/23258160-20150323-06.

11.

Serous macular detachment following a systemic corticosteroid injection.

Weng CY, Harbour JW.

JAMA Ophthalmol. 2015 Apr;133(4):473-4. doi: 10.1001/jamaophthalmol.2014.5237. No abstract available.

PMID:
25856642
12.

Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

Herlihy N, Dogrusöz M, van Essen TH, Harbour JW, van der Velden PA, van Eggermond MC, Haasnoot GW, van den Elsen PJ, Jager MJ.

Invest Ophthalmol Vis Sci. 2015 Jan 15;56(3):1447-58. doi: 10.1167/iovs.14-15250.

PMID:
25593028
13.

Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism.

Chen RW, Harbour JW.

Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):2021-2. doi: 10.1007/s00417-014-2793-1. Epub 2014 Sep 12. No abstract available.

14.

Prognostic parameters in uveal melanoma and their association with BAP1 expression.

van Essen TH, van Pelt SI, Versluis M, Bronkhorst IH, van Duinen SG, Marinkovic M, Kroes WG, Ruivenkamp CA, Shukla S, de Klein A, Kiliç E, Harbour JW, Luyten GP, van der Velden PA, Verdijk RM, Jager MJ.

Br J Ophthalmol. 2014 Dec;98(12):1738-43. doi: 10.1136/bjophthalmol-2014-305047. Epub 2014 Aug 21.

PMID:
25147369
15.

GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?

Field MG, Harbour JW.

Cancer Cell. 2014 Jun 16;25(6):714-5. doi: 10.1016/j.ccr.2014.05.028.

16.

Distinguishing torpedo maculopathy from similar lesions of the posterior segment.

Villegas VM, Schwartz SG, Flynn HW Jr, Capó H, Berrocal AM, Murray TG, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2014 May-Jun;45(3):222-6. doi: 10.3928/23258160-20140410-01. Epub 2014 Apr 17. Review.

PMID:
24738480
17.

Recent developments in prognostic and predictive testing in uveal melanoma.

Field MG, Harbour JW.

Curr Opin Ophthalmol. 2014 May;25(3):234-9. doi: 10.1097/ICU.0000000000000051. Review.

18.

A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.

Harbour JW, Chao DL.

Ophthalmology. 2014 Jun;121(6):1281-8. doi: 10.1016/j.ophtha.2013.12.014. Epub 2014 Jan 28.

19.

Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.

Badiyan SN, Rao RC, Apicelli AJ, Acharya S, Verma V, Garsa AA, DeWees T, Speirs CK, Garcia-Ramirez J, Esthappan J, Grigsby PW, Harbour JW.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):801-5. doi: 10.1016/j.ijrobp.2013.12.014. Epub 2014 Jan 22.

PMID:
24462385
20.

Combined PKC and MEK inhibition for treating metastatic uveal melanoma.

Sagoo MS, Harbour JW, Stebbing J, Bowcock AM.

Oncogene. 2014 Sep 25;33(39):4722-3. doi: 10.1038/onc.2013.555. Epub 2014 Jan 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk